ghk-cu biolab (Copper Peptide) | Research Peptide ghk cu biolab GHK-Cu 50mg
Description
Adverse effects observed in clinical trials include: Gastrointestinal effects: nausea, vomiting, diarrhoea, and constipation particularly during dose escalation
That's why guessing isn't always helpful
Using It What is the BPC-157 + TB-500 dosing schedule
Convenience: Our mobile IV therapy services come to you at your home or office, saving you time and effort
NCT02898454 (androgenetic alopecia, completed 2019 with preliminary positive signals extended in 2022 analyses) clinicaltrials.gov
Less common in clinical compounding contexts but available in some formulations
